Symbionyx
  • Home
  • About
    • Who We Are
    • Team
  • Pipeline
  • News
  • Publications
  • Contact
Select Page

Publications

A sensitization-free dimethyl fumarate (DMF) pro-drug...

Download Publication

Isosorbide Di-(Linoleate/Oleate) Stimulates Prodifferentiation...

Download Publication

A novel fumarate, isosorbide di-(methyl fumarate) (IDMF)...

Download Publication

About Us

We are dedicated to making innovative life improving treatments available for patients who are suffering from autoimmune disorders.

Learn More

Publications

A sensitization-free dimethyl fumarate (DMF) pro-drug...

Isosorbide DiLinoleate-Oleate-Stimulate Prodifferentiation...

A novel fumarate, isosorbide di-(methyl fumarate) (IDMF)...

Recent News

Sytheon/Symbionyx Expand the Scope of Isosorbide Esters

Sytheon/Symbionyx Expand the Scope of Isosorbide Esters

Aug 3, 2021

Transforming a Skin Sensitizer to a NON-Skin Sensitizer Sytheon/Symbionyx researchers published a paper – “A sensitization-free dimethyl fumarate (DMF) pro-drug, isosorbide di-(methyl fumarate) (IDMF), provides a topical treatment candidate for psoriasis” in JID...

Sytheon has published a study in the Journal of Investigative Dermatology

Sytheon has published a study in the Journal of Investigative Dermatology

Jan 14, 2021

Sytheon has published a study in the Journal of Investigative Dermatology, profiling mechanistic details of Isosorbide Di-(Linoleate/Oleate) & supporting its effectiveness for the treatment of xerotic pruritic skin The breakdown of the epidermal barrier and...

Contact Us

315 Wootton Street

Boonton, NJ 07005, USA

info@symbionyx.com

Terms & Conditions | Privacy | Visit our parent company  Sytheon Ltd.

  • Follow
  • Follow